Tag:

China

Latest Headlines

Latest Headlines

Report: Bad lifestyles fuel diagnostics boom in emerging markets

The international research outfit GlobalData sees both factors like unhealthy lifestyles as pushing the in vitro diagnostics markets in some countries to climb by 16% annually, reaching a combined $11.7 billion by 2018. 

CMO outsourcing in Asia expected to reach $60B by 2018

A study conducted by GBI Research predicts that CMO outsourcing in Asia will generate $60 billion in revenues by 2018.

J&J buys first Chinese medical device company

Johnson & Johnson ($JNJ) made a big move in China this week with the purchase of its first medical device company in that country. It picked up Guangzhou Bioseal Biotech for an undisclosed sum.

BioMérieux Q1 2012 sales soar, propelled by China, India

Sales growth surpassing 21% in the Asia-Pacific region helped produce healthy numbers for French in vitro diagnostics player bioMérieux in the company's 2012 first quarter.

Australia jumps into life sciences fray with R&D tax credit

You've heard about China and India becoming increasingly significant locales in the Asia-Pacific region for conducting biotechnology research and drug development. Australia, not so much.

China seizes 77 million tainted drug capsules in crackdown

The crackdown in China on companies that have been using waste leather products to make their drug capsules continues.

China sweeps up dozens in whirlwind drug-capsule probe

Chinese police are all over the chromium-tainted drug capsules.

WSJ: Pfizer poised to sell nutrition biz to Nestlé for $9B-plus

Besides Nestlé, Pfizer had been entertaining offers from Danone and Mead Johnson Nutrition in auctioning off the unit.

Chinese regulators freeze sales of drugs with toxic capsules

The country's drug watchdog has banned the sale of 13 drugs that are made with capsules containing toxic levels of chromium.

Surging research in Asia is an opportunity for us

Consider: The research publications output of Chinese scientists will surpass what their U.S.-based counterparts put out by 2013, according to a recent article in the journal Science.